MC-DX4

N/A

Report date: 2025/05/14 14:17:01

Base Information

Drug NameMC-DX4
Drug Alias NameMC-DX-4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate
Mechanisms of ActionDouble homeobox protein 4 inhibitors
TargetsDouble homeobox protein 4
Therapy Area/IndicationsMuscular Dystrophy, Facioscapulohumeral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMiRecule IncSanofi
China Registration ClassN/A

Develop Information

Active CompaniesMiRecule IncSanofi
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Facioscapulohumeral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A